Neuromuscular Disorder-Targeting Compound 1
Modify Date: 2025-08-20 18:18:32
Neuromuscular Disorder-Targeting Compound 1 structure
|
Common Name | Neuromuscular Disorder-Targeting Compound 1 | ||
|---|---|---|---|---|
| CAS Number | 374538-23-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Neuromuscular Disorder-Targeting Compound 1Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome. |
| Name | 1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- |
|---|---|
| Synonym | More Synonyms |
| Description | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome. |
|---|---|
| Related Catalog | |
| In Vitro | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome[1]. |
| References |
| InChIKey | ASXNINCAPWBRJS-AADWAWOOSA-N |
|---|---|
| SMILES | CCCN1CC(CSC)CC2Cc3[nH]ncc3CC21 |
| Neuromuscular Disorder-Targeting Compound 1 |